Anacor Pharmaceuticals Inc Stock
Equities
US0324201013
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2016 | Anacor Pharmaceuticals : received rival bid before Pfizer deal - filing | RE |
2016 | Anacor Pharmaceuticals : Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel | RE |
Managers | Title | Age | Since |
---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 16-06-23 |
Chief Tech/Sci/R&D Officer | 77 | 04-01-31 | |
Director/Board Member | - | 16-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 16-06-23 |
Bryan Supran
BRD | Director/Board Member | - | 16-06-23 |
Director/Board Member | - | 16-06-23 |
1st Jan change | Capi. | |
---|---|---|
+1.49% | 42.59B | |
+7.58% | 40.65B | |
+48.54% | 40.57B | |
-11.96% | 26.77B | |
+8.13% | 24.81B | |
-24.01% | 18.17B | |
+28.62% | 12.05B | |
-3.01% | 11.7B | |
+7.36% | 11.1B |
- Stock Market
- Equities
- Stock